NPI: 1316915077 · MIAMI, FL 33169 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,334 | $2.75M |
| 2019 | 22,313 | $3.80M |
| 2020 | 22,158 | $3.05M |
| 2021 | 20,798 | $1.78M |
| 2022 | 13,681 | $2.63M |
| 2023 | 1,694 | $341K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,046 | 1,728 | $4.74M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,372 | 1,460 | $4.67M |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,012 | 1,148 | $2.31M |
| A4657 | Syringe, with or without needle, each | 3,533 | 1,476 | $635K |
| J1756 | Injection, iron sucrose, 1 mg | 5,105 | 897 | $572K |
| 85041 | 1,592 | 1,091 | $258K | |
| 85048 | 1,542 | 1,051 | $249K | |
| 82728 | 1,318 | 902 | $213K | |
| 83540 | 1,341 | 911 | $210K | |
| 83550 | 1,338 | 911 | $209K | |
| 83970 | 1,200 | 739 | $196K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 423 | 237 | $47K |
| 82108 | 89 | 65 | $17K | |
| 90674 | 28 | 26 | $9K | |
| G0008 | Administration of influenza virus vaccine | 39 | 30 | $9K |